Valbiotis (FRA:8JD) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8JD Valbiotis SA FRA:8JD
49 GF Score
Price €0.80
GF Value €1.43
! 6 Warning Signs
View Full Analysis

What is Valbiotis 3-Month Share Buyback Ratio?

Valbiotis FRA:8JD +0.89% 49 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates FRA:8JD with a GF Score™ of 49/100 and a GF Value™ of €1.43. The stock has 6 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

FRA:8JD
49GF Score
Valbiotis SA FRA:8JD
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Valbiotis (FRA:8JD) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Valbiotis and its competitors.
Is Valbiotis' 3-Month Share Buyback Ratio too high?
Valbiotis' current 3-Month Share Buyback Ratio is 0.00. Overall, Valbiotis has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Valbiotis' 3-Month Share Buyback Ratio compare to KHC and GIS?
Valbiotis' 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Consumer Packaged Goods company?
A good 3-Month Share Buyback Ratio depends on the Consumer Packaged Goods industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Valbiotis and its competitors. Valbiotis's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valbiotis stock overvalued right now?
Valbiotis (FRA:8JD) has a current 3-Month Share Buyback Ratio of 0.00. The stock's GF Value™ is €1.43, compared to a current price of €0.80 — trading 44.3% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Valbiotis' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Valbiotis (FRA:8JD), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valbiotis (FRA:8JD) Overvalued in 2026?

Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued. The current stock price of €0.80 is trading 44.3% below its estimated GF Value™ of €1.43.

Key valuation signals for FRA:8JD:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: €1.43 vs. price of €0.80 (44.3% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the FRA:8JD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valbiotis Business Description

Other Exchanges ALVAL:France
Address 12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
49GF Score

Get the complete analysis for FRA:8JD

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.80
Price
€1.43
GF Value